Cargando…

Comparison of Different Blood Collection, Sample Matrix, and Immunoassay Methods in a Prenatal Screening Setting

We compared how measurements of pregnancy-associated plasma protein A (PAPP-A) and the free beta subunit of human chorionic gonadotropin (fβ-hCG) in maternal blood are influenced by different methods for blood collection, sample matrix, and immunoassay platform. Serum and dried blood spots (DBS) wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Pennings, Jeroen L. A., Siljee, Jacqueline E., Imholz, Sandra, Kuc, Sylwia, de Vries, Annemieke, Schielen, Peter C. J. I., Rodenburg, Wendy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123521/
https://www.ncbi.nlm.nih.gov/pubmed/25132703
http://dx.doi.org/10.1155/2014/509821
_version_ 1782329504802275328
author Pennings, Jeroen L. A.
Siljee, Jacqueline E.
Imholz, Sandra
Kuc, Sylwia
de Vries, Annemieke
Schielen, Peter C. J. I.
Rodenburg, Wendy
author_facet Pennings, Jeroen L. A.
Siljee, Jacqueline E.
Imholz, Sandra
Kuc, Sylwia
de Vries, Annemieke
Schielen, Peter C. J. I.
Rodenburg, Wendy
author_sort Pennings, Jeroen L. A.
collection PubMed
description We compared how measurements of pregnancy-associated plasma protein A (PAPP-A) and the free beta subunit of human chorionic gonadotropin (fβ-hCG) in maternal blood are influenced by different methods for blood collection, sample matrix, and immunoassay platform. Serum and dried blood spots (DBS) were obtained by venipuncture and by finger prick of 19 pregnant women. PAPP-A and fβ-hCG from serum and from DBS were measured by conventional indirect immunoassay on an AutoDELFIA platform and by antibody microarray. We compared methods based on the recoveries for both markers as well as marker levels correlations across samples. All method comparisons showed high correlations for both marker concentrations. Recovery levels of PAPP-A from DBS were 30% lower, while those of fβ-hCG from DBS were 50% higher compared to conventional venipuncture serum. The recoveries were not affected by blood collection or immunoassay method. The high correlation coefficients for both markers indicate that DBS from finger prick can be used reliably in a prenatal screening setting, as a less costly and minimally invasive alternative for venipuncture serum, with great logistical advantages. Additionally, the use of antibody arrays will allow for extending the number of first trimester screening markers on maternal and fetal health.
format Online
Article
Text
id pubmed-4123521
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-41235212014-08-17 Comparison of Different Blood Collection, Sample Matrix, and Immunoassay Methods in a Prenatal Screening Setting Pennings, Jeroen L. A. Siljee, Jacqueline E. Imholz, Sandra Kuc, Sylwia de Vries, Annemieke Schielen, Peter C. J. I. Rodenburg, Wendy Dis Markers Research Article We compared how measurements of pregnancy-associated plasma protein A (PAPP-A) and the free beta subunit of human chorionic gonadotropin (fβ-hCG) in maternal blood are influenced by different methods for blood collection, sample matrix, and immunoassay platform. Serum and dried blood spots (DBS) were obtained by venipuncture and by finger prick of 19 pregnant women. PAPP-A and fβ-hCG from serum and from DBS were measured by conventional indirect immunoassay on an AutoDELFIA platform and by antibody microarray. We compared methods based on the recoveries for both markers as well as marker levels correlations across samples. All method comparisons showed high correlations for both marker concentrations. Recovery levels of PAPP-A from DBS were 30% lower, while those of fβ-hCG from DBS were 50% higher compared to conventional venipuncture serum. The recoveries were not affected by blood collection or immunoassay method. The high correlation coefficients for both markers indicate that DBS from finger prick can be used reliably in a prenatal screening setting, as a less costly and minimally invasive alternative for venipuncture serum, with great logistical advantages. Additionally, the use of antibody arrays will allow for extending the number of first trimester screening markers on maternal and fetal health. Hindawi Publishing Corporation 2014 2014-07-15 /pmc/articles/PMC4123521/ /pubmed/25132703 http://dx.doi.org/10.1155/2014/509821 Text en Copyright © 2014 Jeroen L. A. Pennings et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Pennings, Jeroen L. A.
Siljee, Jacqueline E.
Imholz, Sandra
Kuc, Sylwia
de Vries, Annemieke
Schielen, Peter C. J. I.
Rodenburg, Wendy
Comparison of Different Blood Collection, Sample Matrix, and Immunoassay Methods in a Prenatal Screening Setting
title Comparison of Different Blood Collection, Sample Matrix, and Immunoassay Methods in a Prenatal Screening Setting
title_full Comparison of Different Blood Collection, Sample Matrix, and Immunoassay Methods in a Prenatal Screening Setting
title_fullStr Comparison of Different Blood Collection, Sample Matrix, and Immunoassay Methods in a Prenatal Screening Setting
title_full_unstemmed Comparison of Different Blood Collection, Sample Matrix, and Immunoassay Methods in a Prenatal Screening Setting
title_short Comparison of Different Blood Collection, Sample Matrix, and Immunoassay Methods in a Prenatal Screening Setting
title_sort comparison of different blood collection, sample matrix, and immunoassay methods in a prenatal screening setting
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4123521/
https://www.ncbi.nlm.nih.gov/pubmed/25132703
http://dx.doi.org/10.1155/2014/509821
work_keys_str_mv AT penningsjeroenla comparisonofdifferentbloodcollectionsamplematrixandimmunoassaymethodsinaprenatalscreeningsetting
AT siljeejacquelinee comparisonofdifferentbloodcollectionsamplematrixandimmunoassaymethodsinaprenatalscreeningsetting
AT imholzsandra comparisonofdifferentbloodcollectionsamplematrixandimmunoassaymethodsinaprenatalscreeningsetting
AT kucsylwia comparisonofdifferentbloodcollectionsamplematrixandimmunoassaymethodsinaprenatalscreeningsetting
AT devriesannemieke comparisonofdifferentbloodcollectionsamplematrixandimmunoassaymethodsinaprenatalscreeningsetting
AT schielenpetercji comparisonofdifferentbloodcollectionsamplematrixandimmunoassaymethodsinaprenatalscreeningsetting
AT rodenburgwendy comparisonofdifferentbloodcollectionsamplematrixandimmunoassaymethodsinaprenatalscreeningsetting